Comprehensive evaluation of leukocyte lineage derived from human hematopoietic cells in humanized mice

Journal of Bioscience and Bioengineering

Volumn 113, Issue 4, 2012, Pages 529-535

  Takahashi, Masayuki ^a   Tsujimura, Noriyuki ^b   Otsuka, Kensuke ^a   Yoshino, Tomoko ^b   Mori, Tetsushi ^b   Matsunaga, Tadashi ^b   Nakasono, Satoshi ^a,b  

^a CENTRAL RESEARCH INSTITUTE OF ELECTRIC POWER INDUSTRY   (Japan)

^b TOKYO UNIVERSITY OF AGRICULTURE AND TECHNOLOGY   (Japan)

Author keywords

Cell transplantation; Hematopoietic stem cell; Humanized mice; Leukocyte lineage; NOG mice

Indexed keywords

CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HUMANIZED MICE; LEUKOCYTE LINEAGE; NOG MICE;

BLOOD; BONE; CYTOLOGY; GENES; HISTOLOGY; STEM CELLS; TISSUE;

MAMMALS;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD; BONE MARROW; CELL DIFFERENTIATION; CELL LINEAGE; CELL MIGRATION; CELL POPULATION; CONTROLLED STUDY; CORD BLOOD STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; LEUKOCYTE; MOUSE; NONHUMAN; PHENOTYPE; SPLEEN; THYMUS;

ANIMALS; BODY WEIGHT; BONE MARROW CELLS; CELL DIFFERENTIATION; CELL LINEAGE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HUMANS; LEUKOCYTES; MALE; MICE; MICE, INBRED NOD; MICE, SCID; SPLEEN;

ANIMALIA; MUS;

EID: 84857688441     PISSN: 13891723     EISSN: 13474421     Source Type: Journal    
DOI: 10.1016/j.jbiosc.2011.11.011     Document Type: Article

References (39)

1. Boutros P.C., Bielefeld K.A., Pohjanvirta R., Harper P.A. Dioxin-dependent and dioxin-independent gene batteries: comparison of liver and kidney in AHR-null mice. Toxicol. Sci. 2009, 112:245-256.
2. Kettunen E., Aavikko M., Nymark P., Ruosaari S., Wikman H., Vanhala E., Salmenkivi K., Pirinen R., Karjalainen A., Kuosma E., Anttila S. DNA copy number loss and allelic imbalance at 2p16 in lung cancer associated with asbestos exposure. Br. J. Cancer 2009, 100:1336-1342.
3. Mazur C.S., Kenneke J.F. Cross-species comparison of conazole fungicide metabolites using rat and rainbow trout (Onchorhynchus mykiss) hepatic microsomes and purified human CYP 3A4. Environ. Sci. Technol. 2008, 42:947-954.
4. Sahi J., Khan K.K., Black C.B. Aldehyde oxidase activity and inhibition in hepatocytes and cytosolic fractions from mouse, rat, monkey and human. Drug Metab. Lett. 2008, 2:176-183.
5. Moriguchi T., Motohashi H., Hosoya T., Nakajima O., Takahashi S., Ohsako S., Aoki Y., Nishimura N., Tohyama C., Fujii-Kuriyama Y., Yamamoto M. Distinct response to dioxin in an arylhydrocarbon receptor (AHR)-humanized mouse. Proc. Natl. Acad. Sci. USA 2003, 100:5652-5657.
6. van Waterschoot R.A., Rooswinkel R.W., Sparidans R.W., van Herwaarden A.E., Beijnen J.H., Schinkel A.H. Inhibition and stimulation of intestinal and hepatic CYP3A activity: studies in humanized CYP3A4 transgenic mice using triazolam. Drug Metab. Dispos. 2009, 37:2305-2313.
7. Katoh M., Matsui T., Nakajima M., Tateno C., Kataoka M., Soeno Y., Horie T., Iwasaki K., Yoshizato K., Yokoi T. Expression of human cytochromes P450 in chimeric mice with humanized liver. Drug Metab. Dispos. 2004, 32:1402-1410.
8. Suemizu H., Hasegawa M., Kawai K., Taniguchi K., Monnai M., Wakui M., Suematsu M., Ito M., Peltz G., Nakamura M. Establishment of a humanized model of liver using NOD/Shi-scid IL2Rgnull mice. Biochem. Biophys. Res. Commun. 2008, 377:248-252.
9. Nakamura T., Miyakawa Y., Miyamura A., Yamane A., Suzuki H., Ito M., Ohnishi Y., Ishiwata N., Ikeda Y., Tsuruzoe N. A novel nonpeptidyl human c-Mpl activator stimulates human megakaryopoiesis and thrombopoiesis. Blood 2006, 107:4300-4307.
10. Watanabe S., Terashima K., Ohta S., Horibata S., Yajima M., Shiozawa Y., Dewan M.Z., Yu Z., Ito M., Morio T. Hematopoietic stem cell-engrafted NOD/SCID/IL2Rgamma null mice develop human lymphoid systems and induce long-lasting HIV-1 infection with specific humoral immune responses. Blood 2007, 109:212-218. and other 3 authors.
11. Basu A., Som A., Ghoshal S., Mondal L., Chaubey R.C., Bhilwade H.N., Rahman M.M., Giri A.K. Assessment of DNA damage in peripheral blood lymphocytes of individuals susceptible to arsenic induced toxicity in West Bengal. India. Toxicol. Lett. 2005, 159:100-112.
12. Jessen B.A., Lee L., Koudriakova T., Haines M., Lundgren K., Price S., Nonomiya J., Lewis C., Stevens G.J. Peripheral white blood cell toxicity induced by broad spectrum cyclin-dependent kinase inhibitors. J. Appl. Toxicol. 2007, 27:133-142.
13. Schellenberger M.T., Grova N., Willieme S., Farinelle S., Prodhomme E.J., Muller C.P. Modulation of benzo[a]pyrene induced immunotoxicity in mice actively immunized with a B[a]P-diphtheria toxoid conjugate. Toxicol. Appl. Pharmacol. 2009, 240:37-45.
14. Farris G.M., Everitt J.I., Irons R.D., Popp J.A. Carcinogenicity of inhaled benzene in CBA mice. Fundam. Appl. Toxicol. 1993, 20:503-507.
15. Ward C.O., Kuna R.A., Snyder N.K., Alsaker R.D., Coate W.B., Craig P.H. Subchronic inhalation toxicity of benzene in rats and mice. Am. J. Ind. Med. 1985, 7:457-473.
16. + B cells develop predominantly in the spleen of NOD/SCID/gammac(null) (NOG) mice transplanted either with human umbilical cord blood, bone marrow, or mobilized peripheral blood CD34+ cells. Exp. Hematol. 2003, 31:789-797. and other 4 authors.
17. Shultz L.D., Lyons B.L., Burzenski L.M., Gott B., Chen X., Chaleff S., Kotb M., Gillies S.D., King M., Mangada J., Greiner D.L., Handgretinger R. Human lymphoid and myeloid cell development in NOD/LtSz-scid IL2R gamma null mice engrafted with mobilized human hemopoietic stem cells. J. Immunol. 2005, 174:6477-6489.
18. Watanabe S., Ohta S., Yajima M., Terashima K., Ito M., Mugishima H., Fujiwara S., Shimizu K., Honda M., Shimizu N., Yamamoto N. Humanized NOD/SCID/IL2Rgamma(null) mice transplanted with hematopoietic stem cells under nonmyeloablative conditions show prolonged life spans and allow detailed analysis of human immunodeficiency virus type 1 pathogenesis. J. Virol. 2007, 81:13259-13264.
19. Watanabe Y., Takahashi T., Okajima A., Shiokawa M., Ishii N., Katano I., Ito R., Ito M., Minegishi M., Minegishi N., Tsuchiya S., Sugamura K. The analysis of the functions of human B and T cells in humanized NOD/shi-scid/gammac(null) (NOG) mice (hu-HSC NOG mice). Int. Immunol. 2009, 21:843-858.
20. Ito M., Hiramatsu H., Kobayashi K., Suzue K., Kawahata M., Hioki K., Ueyama Y., Koyanagi Y., Sugamura K., Tsuji K., Heike T., Nakahata T. NOD/SCID/gamma(c)(null) mouse: an excellent recipient mouse model for engraftment of human cells. Blood 2002, 100:3175-3182.
21. Conneally E., Cashman J., Petzer A., Eaves C. Expansion in vitro of transplantable human cord blood stem cells demonstrated using a quantitative assay of their lympho-myeloid repopulating activity in nonobese diabetic-scid/scid mice. Proc. Natl. Acad. Sci. USA 1997, 94:9836-9841.
22. Wu A.G., Michejda M., Mazumder A., Meehan K.R., Menendez F.A., Tchabo J.G., Slack R., Johnson M.P., Bellanti J.A. Analysis and characterization of hematopoietic progenitor cells from fetal bone marrow, adult bone marrow, peripheral blood, and cord blood. Pediatr. Res. 1999, 46:163-169.
23. + thymocytes. Nature 1987, 330:170-173.
24. Bertho J.M., Demarquay C., Moulian N., Van Der Meeren A., Berrih-Aknin S., Gourmelon P. Phenotypic and immunohistological analyses of the human adult thymus: evidence for an active thymus during adult life. Cell. Immunol. 1997, 179:30-40.
25. Knapp W., Dorken B., Rieber P., Schmidt R.E., Stein H., von dem Borne A.E. CD antigens 1989. Blood 1989, 74:1448-1450.
26. + cell population in hepatocellular carcinoma cell lines. Cancer Sci. 2010, 101:2145-2155. and other 6 authors.
27. Sato K., Nie C., Misawa N., Tanaka Y., Ito M., Koyanagi Y. Dynamics of memory and naive CD8+ T lymphocytes in humanized NOD/SCID/IL-2Rgammanull mice infected with CCR5-tropic HIV-1. Vaccine 2010, 28(Suppl 2):B32-B37.
28. Yamazaki H., Suemizu H., Igaya S., Shimizu M., Shibata N., Nakamura M., Chowdhury G., Guengerich F.P. In vivo formation of a glutathione conjugate derived from thalidomide in humanized uPA-NOG mice. Chem. Res. Toxicol. 2011, 24:287-289.
29. Yahata T., Ando K., Nakamura Y., Ueyama Y., Shimamura K., Tamaoki N., Kato S., Hotta T. Functional human T lymphocyte development from cord blood CD34+ cells in nonobese diabetic/Shi-scid, IL-2 receptor gamma null mice. J. Immunol. 2002, 169:204-209.
30. Pearson T., Shultz L.D., Miller D., King M., Laning J., Fodor W., Cuthbert A., Burzenski L., Gott B., Lyons B. Non-obese diabetic-recombination activating gene-1 (NOD-Rag1 null) interleukin (IL)-2 receptor common gamma chain (IL2r gamma null) null mice: a radioresistant model for human lymphohaematopoietic engraftment. Clin. Exp. Immunol. 2008, 154:270-284. and other 3 authors.
31. Hiramatsu H., Nishikomori R., Heike T., Ito M., Kobayashi K., Katamura K., Nakahata T. Complete reconstitution of human lymphocytes from cord blood CD34+ cells using the NOD/SCID/gammacnull mice model. Blood 2003, 102:873-880.
32. Wood G.W. Macrophages in the thymus. Surv. Immunol. Res. 1985, 4:179-191.
33. Przepiorka D., Smith T.L., Folloder J., Anderlini P., Chan K.W., Korbling M., Lichtiger B., Norfleet F., Champlin R. Controlled trial of filgrastim for acceleration of neutrophil recovery after allogeneic blood stem cell transplantation from human leukocyte antigen-matched related donors. Blood 2001, 97:3405-3410.
34. Roux E., Dumont-Girard F., Starobinski M., Siegrist C.A., Helg C., Chapuis B., Roosnek E. Recovery of immune reactivity after T-cell-depleted bone marrow transplantation depends on thymic activity. Blood 2000, 96:2299-2303.
35. Ruggeri L., Capanni M., Casucci M., Volpi I., Tosti A., Perruccio K., Urbani E., Negrin R.S., Martelli M.F., Velardi A. Role of natural killer cell alloreactivity in HLA-mismatched hematopoietic stem cell transplantation. Blood 1999, 94:333-339.
36. Storek J., Saxon A. Reconstitution of B cell immunity following bone marrow transplantation. Bone Marrow Transplant. 1992, 9:395-408.
37. De Jong W.H., Kroese E.D., Vos J.G., Van Loveren H. Detection of immunotoxicity of benzo[a]pyrene in a subacute toxicity study after oral exposure in rats. Toxicol. Sci. 1999, 50:214-220.
38. Miyata M., Furukawa M., Takahashi K., Gonzalez F.J., Yamazoe Y. Mechanism of 7,12-dimethylbenz[a]anthracene-induced immunotoxicity: role of metabolic activation at the target organ. Jpn. J. Pharmacol. 2001, 86:302-309.
39. Page T.J., O'Brien S., Holston K., MacWilliams P.S., Jefcoate C.R., Czuprynski C.J. 7,12-Dimethylbenz[a]anthracene-induced bone marrow toxicity is p53-dependent. Toxicol. Sci. 2003, 74:85-92.